ADVFN US – Market Content Editor
-
Monday.com Slides as Revenue Outlook Disappoints Despite Q4 Beat
Monday.com (NASDAQ:MNDY) shares sank more than 12% in premarket trading after the AI-powered work management platform issued fiscal 2026 revenue guidance that came in below market expectations, overshadowing a stronger-than-expected fourth quarter. For the fourth quarter, the company reported adjusted earnings of $1.04 per share, topping analyst forecasts of $0.92. Revenue rose 25% year over…
-
Micron Shares Slide After Report on Samsung’s Faster HBM4 Production Plans
Micron Technology (NASDAQ:MU) shares fell about 3.2% on Monday after reports indicated that rival Samsung Electronics is set to begin mass production of next-generation high-bandwidth memory chips sooner than previously expected. According to South Korea’s Yonhap News Agency, Samsung plans to start large-scale production of HBM4 chips as early as this month. The components are…
-
Kyndryl Shares Sink After Q3 Miss and Weaker Full-Year Outlook
Kyndryl Holdings (NYSE:KD) shares plunged more than 32% in premarket trading on Monday after the company reported third-quarter results that missed expectations and cut its revenue outlook for the full year. The IT infrastructure services provider posted adjusted earnings of $0.52 per share for the quarter ended December 31, 2025, well below the $0.67 analysts…
-
Inotiv Slides After Q1 Revenue Falls Short and Losses Deepen
Inotiv, Inc. (NASDAQ:NOTV) shares fell about 3% in premarket trading on Monday after the company posted first-quarter fiscal 2026 results that missed expectations, with slower revenue growth and a wider loss. The contract research group reported first-quarter revenue of $120.9 million, a modest 0.8% increase from a year earlier but well below the analyst consensus…
-
Novo Nordisk Takes Legal Action Against Hims & Hers Over Compounded Semaglutide
Novo Nordisk (NYSE:NVO) has filed a patent infringement lawsuit against telehealth provider Hims & Hers (NYSE:HIMS) in the United States, targeting the company’s sale and promotion of compounded semaglutide products, according to a statement from the Danish drugmaker. Novo Nordisk alleges that Hims & Hers violated U.S. Patent 8,129,343 by marketing compounded versions of semaglutide…
-
Waters Slides After Q1 Outlook Falls Short Despite Solid Q4 Beat
Waters Corporation (NYSE:WAT) shares dropped more than 3% in premarket trading on Monday after the company issued first-quarter earnings guidance that missed market expectations, overshadowing better-than-expected fourth-quarter results. The analytical instruments group reported fourth-quarter adjusted earnings of $4.53 per share, narrowly topping analyst forecasts of $4.51. Revenue came in at $932 million, also slightly ahead…
-
Nexxen International Surges on Reported Takeover Interest
Nexxen International (NASDAQ:NEXN) shares rallied about 18% in premarket trading on Monday following a report suggesting the advertising technology company has attracted acquisition interest. According to Sky News journalist Mark Kleinman, writing in a post on X, a potential buyer is considering an offer valuing Nexxen at no less than $10 per share. The prospect…
-
Becton Dickinson Slides Despite Q1 Beat as Full-Year Outlook Disappoints
Becton Dickinson (NYSE:BDX) shares dropped nearly 3% in premarket trading on Monday after the medical technology group posted better-than-expected first-quarter results but issued full-year guidance that fell well short of market expectations. The stock was down 2.74% before the opening bell following the earnings release. For the first quarter, the company reported adjusted earnings of…
-
Dynatrace Jumps as Q3 Results Beat Expectations and Full-Year Guidance Is Lifted
Dynatrace (NYSE:DT) shares rallied more than 10% in premarket trading on Monday after the AI-driven software group delivered stronger-than-expected third-quarter results for fiscal 2026 and upgraded its outlook for the full year. The observability platform provider reported fiscal Q3 earnings per share of $0.44, ahead of the $0.41 analysts had forecast. Revenue reached $515 million,…
-
Alibaba’s Qwen Halts AI Coupon Push After Order Surge Overloads System
Alibaba’s AI chatbot Qwen has temporarily stopped issuing shopping coupons after a wave of demand overwhelmed its systems, complicating the group’s efforts to reposition the tool as a transaction-enabled shopping assistant rather than a simple Q&A bot. U.S.-listed shares of Alibaba (NYSE:BABA) slipped about 1% in premarket trading following the news. Qwen began handing out…